Iovance Biotherapeutics Inc Net Asset Quality Index
Iovance Biotherapeutics Inc net asset quality index. Iovance Biotherapeutics Inc (IOVA) has a Net Asset Quality Index of 77.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $904.95 Million minus total liabilities of $202.66 Million yields net assets of $702.29 Million. A higher index indicates a stronger, lower-leverage balance sheet. See IOVA book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Iovance Biotherapeutics Inc (2008–2024)
Net asset quality index of Iovance Biotherapeutics Inc from 2008 to 2024. This chart shows how Iovance Biotherapeutics Inc's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the index stands at 77.6%, representing net assets of $702.29 Million against total assets of $904.95 Million USD. Check strategic asset allocation of Iovance Biotherapeutics Inc to assess the company's strategic physical and investment asset allocation.
Iovance Biotherapeutics Inc Net Asset Quality Index by Year (2008–2024)
Iovance Biotherapeutics Inc net asset quality index by year from 2008 to 2024. The table below presents the year-by-year Net Asset Quality Index for Iovance Biotherapeutics Inc from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Iovance Biotherapeutics Inc (IOVA) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 78.0% | $710.40 Million | $910.43 Million | $200.02 Million | ▲ +3.1 pp |
| 2023 | 74.9% | $584.61 Million | $780.35 Million | $195.74 Million | ▼ -0.3 pp |
| 2022 | 75.2% | $499.64 Million | $663.98 Million | $164.34 Million | ▼ -4.7 pp |
| 2021 | 80.0% | $621.66 Million | $777.33 Million | $155.67 Million | ▼ -5.5 pp |
| 2020 | 85.4% | $656.50 Million | $768.46 Million | $111.96 Million | ▼ -1.3 pp |
| 2019 | 86.7% | $298.97 Million | $344.65 Million | $45.68 Million | ▼ -10.2 pp |
| 2018 | 97.0% | $466.19 Million | $480.82 Million | $14.63 Million | ▲ +3.3 pp |
| 2017 | 93.6% | $145.48 Million | $155.37 Million | $9.89 Million | ▼ -3.5 pp |
| 2016 | 97.1% | $166.92 Million | $171.89 Million | $4.97 Million | ▼ -1.3 pp |
| 2015 | 98.5% | $104.02 Million | $105.65 Million | $1.63 Million | ▲ +2.0 pp |
| 2014 | 96.4% | $44.85 Million | $46.51 Million | $1.66 Million | ▲ +7.8 pp |
| 2013 | 88.6% | $17.60 Million | $19.87 Million | $2.27 Million | ▲ +38573.2 pp |
| 2012 | -38484.6% | $-11.32 Million | $29.41K | $11.35 Million | ▼ -36236.1 pp |
| 2011 | -2248.5% | $-12.78 Million | $568.43K | $13.35 Million | ▼ -2292.1 pp |
| 2010 | 43.7% | $638.09K | $1.46 Million | $822.87K | ▲ +183.7 pp |
| 2009 | -140.0% | $-13.49K | $9.63K | $23.12K | ▼ -180.7 pp |
| 2008 | 40.7% | $2.28K | $5.61K | $3.33K | — |